Vasculitis Trial, Recruiting (NCT03647852)

Vasculitis Trial, Recruiting NCT03647852 Sponsor: Children's Hospital of Fudan University Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT03647852 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children or adolescents between 2 and 16 years old (any gender)
People diagnosed with IgA vasculitis (a condition where the immune system causes inflammation in small blood vessels) that affects the digestive system
People whose illness has been ongoing for less than 2 months
People whose condition has not responded well to standard doses of a steroid medication called prednisolone (below 2mg per kilogram of body weight per day)

Who may not be able to join:

People with a serious, life-threatening body-wide infection (severe sepsis)
People with an infection affecting the brain or spinal cord
People with severe pneumonia (a serious lung infection)
People with a long-term (chronic) infection, such as Epstein-Barr virus (EBV), cytomegalovirus (CMV), or tuberculosis
People with serious chronic kidney disease that requires dialysis or another form of kidney replacement treatment
People with serious complications affecting the brain or nervous system, such as bleeding in the brain or nerve damage

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Li Sun, MD, Children's Hospital of Fudan University

Phone: +8618017590930

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03647852

Sponsor: Children's Hospital of Fudan University

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: +8618017590930

More information: https://clinicaltrials.gov/study/NCT03647852

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children or adolescents between 2 and 16 years old (any gender)
People diagnosed with IgA vasculitis (a condition where the immune system causes inflammation in small blood vessels) that affects the digestive system
People whose illness has been ongoing for less than 2 months
People whose condition has not responded well to standard doses of a steroid medication called prednisolone (below 2mg per kilogram of body weight per day)

Who may not be able to join:

People with a serious, life-threatening body-wide infection (severe sepsis)
People with an infection affecting the brain or spinal cord
People with severe pneumonia (a serious lung infection)
People with a long-term (chronic) infection, such as Epstein-Barr virus (EBV), cytomegalovirus (CMV), or tuberculosis
People with serious chronic kidney disease that requires dialysis or another form of kidney replacement treatment
People with serious complications affecting the brain or nervous system, such as bleeding in the brain or nerve damage

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Children's Hospital of Fudan University

Registry

ClinicalTrials.gov

Start date

1 September 2019

Est. completion

27 February 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

sustained abdominal pain relief

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov